imr_introspective_market_research_logo_original-ezgif.com-webp-to-jpg-converter.jpg
Clinical Trial Outsourcing Market Expected To Reach USD 111.01 Billion by 2032, Growing at a CAGR of 8.7% From 2024-2032 | Introspective Market Research
December 19, 2024 06:27 ET | Introspective Market Research
United Kingdom, London, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Australian healthcare technology company Resonance Health completed the acquisition of 100% of clinical research center TrialsWest for a...
NeuroSigma.png
New Clinical Trial of eTNS for Pediatric ADHD to Commence at Denmark’s Center for Evidence-Based Psychiatry
December 11, 2024 09:00 ET | NeuroSigma, Inc.
LOS ANGELES, Dec. 11, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company, announced today that the Center for Evidence-Based Psychiatry (CEBP) in Denmark has...
Logo_Horizontal_Fill_White_Transparent.png
Neurona Therapeutics Presents Positive Clinical Update: New Data from NRTX-1001 Cell Therapy Trial in Drug-Resistant Epilepsy Announced at 2024 Annual Meeting of the American Epilepsy Society
December 06, 2024 12:00 ET | Neurona Therapeutics
Neurona Therapeutics Presents Positive Clinical Update: New Data from NRTX-1001 Cell Therapy Trial in Drug-resistant Epilepsy Announced at 2024 Annual Meet
Transparency Market Research
Technetium-99m Market Poised for Growth, Projected to Reach Over US$ 8.6 Billion by 2034 | Transparency Market Research
November 28, 2024 09:30 ET | Transparency Market Research
Wilmington, Delaware, Transparency Market Research, Inc., Nov. 28, 2024 (GLOBE NEWSWIRE) -- The Technetium-99m market (Marché du technétium-99m) is experiencing significant growth due to its...
DANNCE.AI
DANNCE.AI Raises $2.6 Million; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform to Characterize Drug Effects and Optimize Neurological Care
November 21, 2024 09:00 ET | DANNCE.AI
DANNCE.AI Raises $2.6 Million; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform.
cmi_logo.png
[Latest] Global Apheresis Equipment Market Size/Share Worth USD 13,169.1 Million by 2033 at a 12.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
November 21, 2024 01:30 ET | Custom Market Insights
Austin, TX, USA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Apheresis Equipment Market Size, Trends and Insights By Product Type...
cmi_logo.png
[Latest] Global Epilepsy Treatment Devices Market Size/Share Worth USD 787.3 Million by 2033 at a 4.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
November 19, 2024 11:30 ET | Custom Market Insights
Austin, TX, USA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Epilepsy Treatment Devices Market Size, Trends and Insights By Product Type...
befast_book
How a 5-Year-Old is Helping Save Lives: New Book by Telestroke CEO & Son Teaches Kids to Spot Stroke Signs
October 29, 2024 08:45 ET | Sevaro Health
On World Stroke Day, Sevaro CEO Dr. Raj Narula and son release B.E.F.A.S.T., Be A Superhero, a children’s book teaching kids to recognize stroke symptoms.
NeuroOne_Logo.jpg
NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference
October 24, 2024 09:00 ET | NeuroOne Medical Technologies
NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference
Figure 1
Trethera Announces Presentation at the Rare Neuroimmune Disorders Symposium Annual Meeting
October 15, 2024 11:48 ET | Trethera Corporation
LOS ANGELES, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for...